ALDH1B1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.165800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.304600E-01
Normal-vs-Stage2
7.808200E-01
Normal-vs-Stage3
6.053800E-01
Normal-vs-Stage4
6.933600E-01
Stage1-vs-Stage2
6.444600E-01
Stage1-vs-Stage3
4.516000E-01
Stage1-vs-Stage4
5.952400E-01
Stage2-vs-Stage3
8.046600E-01
Stage2-vs-Stage4
9.452200E-01
Stage3-vs-Stage4
7.362400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.377400E-01
Normal-vs-AfricanAmerican
9.902600E-01
Normal-vs-Asian
6.602200E-01
Caucasian-vs-AfricanAmerican
7.639200E-01
Caucasian-vs-Asian
5.176800E-01
AfricanAmerican-vs-Asian
4.220600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.271200E-01
Normal-vs-Female
7.877000E-01
Male-vs-Female
9.366800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.802600E-01
Normal-vs-Age(41-60Yrs)
8.280600E-01
Normal-vs-Age(61-80Yrs)
7.975400E-01
Normal-vs-Age(81-100Yrs)
8.152600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.771700E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.262100E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.596600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.253600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.963000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.263600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.289600E-01
Normal-vs-Daily Drinker
5.694600E-01
Normal-vs-Weekly Drinker
5.141000E-01
Normal-vs-Occasional Drinker
8.622600E-01
Normal-vs-Social Drinker
5.412000E-01
Non Drinker-vs-Daily Drinker
6.839600E-01
Non Drinker-vs-Weekly Drinker
1.101010E-01
Non Drinker-vs-Occasional Drinker
7.385800E-01
Non Drinker-vs-Social Drinker
1.244590E-01
Daily Drinker-vs-Weekly Drinker
8.767800E-02
Daily Drinker-vs-Occasional Drinker
4.884000E-01
Daily Drinker-vs-Social Drinker
1.023040E-01
Weekly Drinker-vs-Occasional Drinker
1.398360E-01
Weekly Drinker-vs-Social Drinker
9.032800E-01
Occasional Drinker-vs-Social Drinker
1.531770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.850200E-01
Normal-vs-Grade 2
4.978400E-01
Normal-vs-Grade 3
4.728600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.806000E-01
Grade 1-vs-Grade 3
9.396000E-01
Grade 1-vs-Grade 4
6.850200E-01
Grade 2-vs-Grade 3
5.188000E-01
Grade 2-vs-Grade 4
4.978400E-01
Grade 3-vs-Grade 4
4.728600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.921000E-01
Normal-vs-NonDiabetic
8.970800E-01
Diabetic-vs-NonDiabetic
2.802800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.838800E-01
Normal-vs-NoPancreatitis
8.628600E-01
Pancreatitis-vs-NoPancreatitis
5.051400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.720800E-01
Normal-vs-N1
8.157400E-01
N0-vs-N1
6.990400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.711400E-01
Normal-vs-TP53-NonMutant
9.942600E-01
TP53-Mutant-vs-TP53-NonMutant
6.270400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
